I absolutely agree there are many processing issues with the Quantiferon test that can cause a false positive.  Like any other test, the Quantiferon will have a margin of error, therefore other clinical tools and judgment need to be exercised when trying to make determinations.  I believe the whole picture needs to be taken into account such as incidence of TB in your area, patient history and so forth. 

Thank you,

Karen

 

From: MCOH-EH [mailto:mcoh-eh-bounces@mylist.net] On Behalf Of Kathy Dayvault
Sent: Wednesday, July 30, 2014 3:33 PM
To: 'MCOH/EH'
Subject: Re: [MCOH-EH] [Bulk] Re: [Bulk] Re: Quantiferon gold TB test - preplacement question

 

I am not trying to be adversarial or offensive in my post and apologize if it came across that way.

 

My post  is a result of  managing OHS services for a large HC facility in GA and now serve as a TB educator.

 

At the HC organization, we developed a robust TB medical surveillance program. Following up one test type with another is problematic I have faced some of the same issues. We chose to utilize only one test type… an IGRA test.

 

False positives when using Quantiferon gold are often a result of some type of error in following the pre-analytical steps in the phlebotomy process:

1.       Failure to use a waste tube when using a butterfly

2.       Drawing the tubes in the right order: gray red and then purple

3.       Shaking or inverting them 10 times- too much, too vigorous or not enough might cause issues

4.       Making sure the sample was incubated within the appropriate time frame from being drawn- 16 hours.

5.       And finally the appropriate incubation period before resulting out.

 

I have spoke with a lab manager who performed QFT in house who identified that often a break in the pre-analytical steps was the culprit.

 

Is there harm in using both tests? No… but which result do you trust for identifying latent TB?

 

In GA, when an individual is diagnosed with latent TB and refuses care or treatment, they can be held legally liable if someone becomes ill as a result of the progression of latent TB….huge concern for a healthcare facility.. attaching the link to refusal of care. When calling the GA TB unit, it is not unusual to speak to someone from the CDC. They are great people to talk to and a huge resource.

 

http://dph.georgia.gov/sites/dph.georgia.gov/files/TB-FormLegal_3575.Ref.Eng_2011.pdf

 

Thanks,

 

Kathy

 

Kathy Dayvault, RN, BSN, MPH, COHN-S/CM

Independant Occupational Health Nurse Consultant

JET Consulting

kdayvault11@att.net

 

 

 

 

 

 

From: MCOH-EH [mailto:mcoh-eh-bounces@mylist.net] On Behalf Of Morelli, Karen J
Sent: Wednesday, July 30, 2014 2:53 PM
To: 'MCOH/EH'
Subject: [Bulk] Re: [MCOH-EH] [Bulk] Re: Quantiferon gold TB test - preplacement question

 

It is true that the the IGRA test and PPD are two separate methodologies.  And, yes, it is true that the Quantiferon is more specific.  However, in the light of the fact that there have been issues with false positive Quantiferon results after ppd placements, I don’t see the harm in placing a PPD to gather more information.  We live in a low incidence Tb area as well and have been told that there are more incidents of false positive Quantiferon results in low TB incident regions.  The following excerpt is my correspondence with the CDC concerning this subject:

 

Thank you for your inquiry to CDC-INFO. We are sorry for the delay in responding to your e-mail. A recent high volume of inquiries has slowed our response time.  Your request for information on running quantiferon gold after tuberculin skin test was forwarded to subject-matter experts at the CDC Division of Tuberculosis Elimination (DTBE). We are pleased to provide you with their response.

 

There is no CDC guidance, or guidance from any other expert source, that IGRA should not be used after a tuberculin skin test at any specific point in time; however; it is our opinion that the theoretical timing of potential boosting bears consideration, but it does not constitute advice on whether or not to use IGRA methods or when to use them.

 

There is a little evidence that boosting of the QFT-GIT may take > 3 days after TST placement. Some investigators have reported evidence of boosting for as long as 6 months. We do not know how long boosting of IGRAs after a TST may last so have adopted the interval applied to clinical decisions for serial TSTs. We think that boosting of QFT-GIT after a TST may last up to 1 year.

 

The related paragraph in the IGRA guidelines reads as follows “Investigations examining the effect of PPD injection on sub­sequent IGRAs have produced conflicting results (59,62–66); outcome differences probably are attributable to differences in the study population (infected versus noninfected subjects, recent versus temporally remote infection, and risk for ongoing exposure), timing of IGRA testing after PPD injection, the IGRA format, and the definition of boosting used. PPD injection should be expected to boost anamnestic immune responses measured by IGRA originating from M. tuberculosis infection, but not from BCG vaccination or in nonsensitized persons. Additional studies examining the effect of PPD injection on IFN-? responses are needed to define the frequency, magnitude, induction time, and longevity of IGRA boosting following a TST.”

 

Links to nonfederal organizations are provided as a service. Links are not an endorsement of these organizations or their programs by CDC or the federal government. CDC is not responsible for the content of organization websites found at these links.

 

Thank you for contacting CDC-INFO. For more information, please call 1-800-CDC-INFO (800-232-4636) or visit www.cdc.gov/info.

 

CDC-INFO is a service of the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry (ATSDR). This service is provided by Verizon and its subcontractors under the Networx Universal contract to CDC.

 

------------------------------------------------------------------------------------------------------------

Thank you,

 

LH

 

 

Karen

 

From: MCOH-EH [mailto:mcoh-eh-bounces+kmorelli=emhs.org@mylist.net] On Behalf Of Kathy Dayvault
Sent: Wednesday, July 30, 2014 2:26 PM
To: 'MCOH/EH'
Subject: Re: [MCOH-EH] [Bulk] Re: Quantiferon gold TB test - preplacement question

 

They are not the same tests. You can have a negative PPD and a positive IGRA test… you cannot use them to check each other’s validity for pos or neg response.

 

Thanks,

Kathy Dayvault, RN, BSN, MPH, COHN-S/CM

Independant Occupational Health Nurse Consultant

JET Consulting

kdayvault11@att.net

 

 

 

 

 

From: MCOH-EH [mailto:mcoh-eh-bounces@mylist.net] On Behalf Of Morelli, Karen J
Sent: Wednesday, July 30, 2014 2:14 PM
To: 'MCOH/EH'
Subject: [Bulk] Re: [MCOH-EH] Quantiferon gold TB test - preplacement question

 

You could always do a ppd (since she had a documented negative ppd one month ago, we would only do a one-step) to verify the accuracy of the Quantiferon.

 

Thank you,

Karen Morelli RN, BSN

 

From: MCOH-EH [mailto:mcoh-eh-bounces@mylist.net] On Behalf Of Band, Michael DO
Sent: Wednesday, July 30, 2014 2:10 PM
To: 'MCOH/EH'
Subject: Re: [MCOH-EH] Quantiferon gold TB test - preplacement question

 

Sorry

 

Trying to type between patients.

 

Yes her quantiferon gold TB test was positive, neg ppd.   I am worried this is a false positive.

 

Michael Band DO, MS

 

From: MCOH-EH [mailto:mcoh-eh-bounces+mband=watsonclinic.com@mylist.net] On Behalf Of Morelli, Karen J
Sent: Wednesday, July 30, 2014 2:07 PM
To: 'MCOH/EH'
Subject: Re: [MCOH-EH] Quantiferon gold TB test - preplacement question

 

I assume you meant to type that the Quantiferon is positive now after a negative ppd one month ago.  I have been monitoring the Quantiferon issue since we had a cluster of false positives last fall (presumably due to tube/process issues).  The research I have done states that Quantiferon could be run within a 3 day window of receiving a ppd, after that there is a chance of getting a false positive reading on the Quantiferon (from the ppd plant).  There is no concrete “cut off” time frame that I have seen to know when it would be okay to run a Quantiferon after a ppd.  The TB expert in my area stated that false positive Quantiferon tests have been noted up to 6 weeks after a ppd.  Due to the uncertainty of when it would be okay to run a Quantiferon after a ppd, our department has adopted a 6 months cut off time. 

 

Thank you,

Karen Morelli RN, BSN

Eastern Maine Healthcare Systems

 

From: MCOH-EH [mailto:mcoh-eh-bounces@mylist.net] On Behalf Of Band, Michael DO
Sent: Wednesday, July 30, 2014 1:41 PM
To: mcoh-eh@mylist.net
Subject: [MCOH-EH] Quantiferon gold TB test - preplacement question

 

Currently we are using the quantiferon gold TB test for use after a positive ppd for preplacement.

 

Every once in a while a new doctor or employee are not available for a 48-72 hour ppd read so we do quantiferon instead.

 

Had a new doctor with a negative ppd one month ago at another facility and her quantiferon gold is negative.

 

NO symptoms of active TB and no known exposures.  She is in a low risk specialty for TB exposure.

 

Chest xay normal

 

Question:

 

1.        I read somewhere that a recent ppd can interfere with the quantiferon gold test.  Not sure if this is true?

 

2.       What is the next step?  Do we call this latent Tb?  Is it worth repeating the quantiferon gold test?  Could this be a false positive?

 

Thanks for any help.

 

Michael Band DO, MS

Watson Clinic

NOTICE OF CONFIDENTIALITY
---------------------------------------------------

The information in this email, including attachments, may be confidential and/or privileged
and may contain confidential health information. 
This email is intended to be reviewed only by the individual or organization named as addressee. 
If you have received this email in error please notify Watson Clinic immediately
by return message to the sender or to administrator@watsonclinic.com
Destroy all copies of this message and any attachments. 
Please note that any views or opinions presented in this email are solely those of the author
and do not necessarily represent those of Watson Clinic. 
Confidential health information is protected by state and federal law, including, but not limited to:
The Health Insurance Portability and Accountability Act of 1996 and related regulations.

-------------------------------------------------------------------------------------------------------------------
This email message, including any associated files, is for the sole use of the intended recipient(s) and may contain information that is confidential, privileged, or subject to copyright, trade secret or other protection. This message also may contain information protected by state and federal privacy laws that are enforced through serious civil and criminal sanctions. Any unauthorized review, use, disclosure, or distribution is prohibited. If you are not an intended recipient of this message, please notify the sender immediately by replying to this e-mail, and delete the original and all copies of this message from your computer or other device.

-------------------------------------------------------------------------------------------------------------------
This email message, including any associated files, is for the sole use of the intended recipient(s) and may contain information that is confidential, privileged, or subject to copyright, trade secret or other protection. This message also may contain information protected by state and federal privacy laws that are enforced through serious civil and criminal sanctions. Any unauthorized review, use, disclosure, or distribution is prohibited. If you are not an intended recipient of this message, please notify the sender immediately by replying to this e-mail, and delete the original and all copies of this message from your computer or other device.

-------------------------------------------------------------------------------------------------------------------
This email message, including any associated files, is for the sole use of the intended recipient(s) and may contain information that is confidential, privileged, or subject to copyright, trade secret or other protection. This message also may contain information protected by state and federal privacy laws that are enforced through serious civil and criminal sanctions. Any unauthorized review, use, disclosure, or distribution is prohibited. If you are not an intended recipient of this message, please notify the sender immediately by replying to this e-mail, and delete the original and all copies of this message from your computer or other device.

-------------------------------------------------------------------------------------------------------------------
This email message, including any associated files, is for the sole use of the intended recipient(s) and may contain information that is confidential, privileged, or subject to copyright, trade secret or other protection. This message also may contain information protected by state and federal privacy laws that are enforced through serious civil and criminal sanctions. Any unauthorized review, use, disclosure, or distribution is prohibited. If you are not an intended recipient of this message, please notify the sender immediately by replying to this e-mail, and delete the original and all copies of this message from your computer or other device.